Oncogenic JAK1 and JAK2-activating mutations resistant to ATP-competitive inhibitorsTekla Hornakova, Jean‐Christophe Renauld|Haematologica|2011Cited by 77
Acute Lymphoblastic Leukemia-associated JAK1 Mutants Activate the Janus Kinase/STAT Pathway via Interleukin-9 Receptor α HomodimersTekla Hornakova, Jean‐Christophe Renauld|Journal of Biological Chemistry|2009Cited by 65
ALL-associated JAK1 mutations confer hypersensitivity to the antiproliferative effect of type I interferonTekla Hornakova, Laurent Knoops|Blood|2010Cited by 26